BankPlus Trust Department’s AbbVie ABBV Stock Holding History

BankPlus Trust Department’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.77M	Buy	26,903 +437	+2%	+$94K	1.58%	8
2026 Q1	$5.76M	Sell	26,466 -1,442	-5%	-$320K	1.54%	7
2025 Q4	$6.38M	Sell	27,908 -157	-0.6%	-$35.8K	1.67%	8
2025 Q3	$6.5M	Buy	28,065 +952	+4%	+$194K	1.74%	7
2025 Q2	$5.03M	Buy	27,113 +855	+3%	+$159K	1.49%	8
2025 Q1	$5.5M	Buy	26,258 +34	+0.1%	+$6.61K	1.84%	8
2024 Q4	$4.66M	Buy	+26,224	New	+$4.82M	1.53%	8

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BankPlus Trust Department's ABBV Position: Q2 2026 in Review

BankPlus Trust Department increased its AbbVie (ABBV) stake by 1.7% in Q2 2026, buying an estimated $94K and bringing the position to 26,903 shares worth $6.77M. The position accounts for 1.58% of the portfolio, ranked #8.

BankPlus Trust Department first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,227 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

BankPlus Trust Department held 26,903 shares of AbbVie worth $6.77M as of Q2 2026.
BankPlus Trust Department bought 437 AbbVie shares in Q2 2026, an estimated $94K.
AbbVie made up 1.58% of BankPlus Trust Department's portfolio in Q2 2026, its #8 holding.
BankPlus Trust Department first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,227 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.